DI
ABBV icon

Disciplined Investments’s AbbVie ABBV Stock Holding History

Disciplined Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$494K Buy
2,270
+1,251
+123% +$278K 0.18% 86
2025
Q4 		$233K Buy
+1,019
New +$232K 0.09% 112
2023
Q3 		– Sell
-602
Closed -$81.1K – 112
2023
Q2 		$81.1K Sell
602
-34
-5% -$4.99K 0.04% 167
2023
Q1 		$101K Sell
636
-24
-4% -$3.67K 0.04% 166
2022
Q4 		$107K Sell
660
-85
-11% -$13K 0.05% 137
2022
Q3 		$100K Sell
745
-47
-6% -$6.74K 0.05% 158
2022
Q2 		$121K Buy
792
+31
+4% +$4.74K 0.05% 150
2022
Q1 		$123K Sell
761
-47
-6% -$6.83K 0.05% 153
2021
Q4 		$109K Buy
808
+320
+66% +$37.8K 0.05% 148
2021
Q3 		$53K Hold
488
– – 0.03% 197
2021
Q2 		$55K Buy
488
+110
+29% +$12.4K 0.03% 190
2021
Q1 		$41K Buy
378
+12
+3% +$1.28K 0.02% 189
2020
Q4 		$39K Hold
366
– – 0.03% 164
2020
Q3 		$32K Sell
366
-437
-54% -$41.1K 0.02% 184
2020
Q2 		$79K Hold
803
– – 0.06% 129
2020
Q1 		$61K Buy
803
+12
+2% +$1.02K 0.06% 137
2019
Q4 		$70K Buy
+791
New +$65.7K 0.06% 141

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Disciplined Investments's ABBV Position: Q1 2026 in Review

Disciplined Investments increased its AbbVie (ABBV) stake by 123% in Q1 2026, buying an estimated $278K and bringing the position to 2,270 shares worth $494K. The position accounts for 0.18% of the portfolio, ranked #86.

Disciplined Investments first reported a position in ABBV in Q4 2019 and has held it in 17 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Disciplined Investments held 2,270 shares of AbbVie worth $494K as of Q1 2026.
  • Disciplined Investments bought 1,251 AbbVie shares in Q1 2026, an estimated $278K.
  • AbbVie made up 0.18% of Disciplined Investments's portfolio in Q1 2026, its #86 holding.
  • Disciplined Investments first reported a position in AbbVie in Q4 2019 and has held it in 17 quarters since.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Disciplined Investments's 13F filing for Q1 2026, filed 12 May 2026.